Data is not available at this time.
Polar Capital Global Healthcare Trust plc is a UK-domiciled closed-end equity fund specializing in global healthcare investments. Managed by Polar Capital LLP, the fund targets large-cap healthcare companies with market capitalizations exceeding $5 billion, focusing on pharmaceuticals, biotechnology, medical devices, and services. Its investment strategy combines fundamental analysis with a bottom-up stock-picking approach, aiming to deliver growth and income through dividend-paying equities. The fund benchmarks against the MSCI ACWI/Health Care Index, providing investors with exposure to a diversified portfolio of established healthcare leaders. The healthcare sector's defensive characteristics and long-term growth potential underpin the fund's market positioning, appealing to investors seeking stability amid economic volatility. Polar Capital’s expertise in healthcare investing enhances its ability to identify high-quality companies with sustainable competitive advantages, reinforcing its reputation in the asset management space.
For the fiscal year ending September 2024, the trust reported revenue of 65.51 million GBp and net income of 62.80 million GBp, reflecting strong profitability. Diluted earnings per share stood at 0.52 GBp, supported by efficient portfolio management and a focus on dividend-paying growth stocks. Operating cash flow was robust at 49.01 million GBp, with no capital expenditures, indicating high cash generation efficiency.
The trust demonstrates solid earnings power, with a net income margin of approximately 96%, highlighting effective cost management and investment selection. Its capital efficiency is further evidenced by the absence of debt and a cash position of 9.55 million GBp, providing flexibility for future investments or shareholder returns. The fund’s focus on large-cap healthcare stocks contributes to stable earnings and lower volatility.
Polar Capital Global Healthcare Trust maintains a strong balance sheet, with no debt and cash reserves of 9.55 million GBp. This conservative financial structure enhances resilience and supports dividend distributions. The trust’s asset base is primarily composed of equity investments in high-quality healthcare companies, aligning with its long-term growth and income objectives.
The trust has a clear focus on growth and income, with a dividend per share of 2.4 GBp, appealing to income-seeking investors. The healthcare sector’s inherent growth drivers, such as aging populations and innovation, provide a favorable backdrop for long-term appreciation. The fund’s strategy of investing in large-cap, dividend-paying stocks aligns with its growth and income mandate.
With a market capitalization of 382 million GBp and a beta of 0.52, the trust is positioned as a lower-risk investment within the healthcare sector. Its valuation reflects investor confidence in its ability to deliver stable returns, supported by the defensive nature of healthcare stocks and Polar Capital’s active management expertise.
The trust benefits from Polar Capital’s specialized healthcare investment expertise and a disciplined stock selection process. The long-term outlook for the healthcare sector remains positive, driven by demographic trends and technological advancements. The fund’s focus on high-quality, dividend-paying companies positions it well to capitalize on these trends while providing income stability.
Company description, financial data, and market metrics provided in the input.
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |